Consumer Healthcare Market to record USD 123.78 Bn growth; North America to have a significant market share -- Technavio
NEW YORK, Oct. 7, 2022 /PRNewswire/ -- The global consumer healthcare market size is expected to grow by USD 123.78 billion, accelerating at a CAGR of 5.66% between 2021 and 2026. According to the report, the market structure is fragmented due to the presence of several large and small vendors. The vendors in the market are adopting various strategies such as new product launches and strategic alliances to remain competitive and gain an edge over their rivals. Get detailed insights into the vendor landscape, successful strategies adopted by vendors, key product launches, and more by purchasing our full report. Download Sample PDF Report Before Purchasing
The report identifies Abbott Laboratories, Amway Corp., BASF SE, Bayer AG, BioGaia AB, Boehringer Ingelheim International GmbH, Chr Hansen Holding AS, Danone SA, Eisai Co. Ltd., Genomma Lab Internacional SAB de CV, Glanbia Plc, GlaxoSmithKline Plc, Herbalife Nutrition Ltd., Himalaya Global Holdings Ltd., Johnson and Johnson, Kellogg Co., Koninklijke DSM NV, Merck KGaA, Nestle SA, NUTRITION ET SANTE, Pfizer Inc., Reckitt Benckiser Group PLC, and Sanofi as major market participants. Although increasing awareness about lifestyle diseases will offer immense growth opportunities, intense competition will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The global consumer healthcare market is segmented as below:
Product
OTC Pharmaceuticals
Dietary Supplements
The market growth in the OTC pharmaceuticals segment will be significant over the forecast period. The segment is driven by the easy availability of OTC pharmaceuticals in pharmacies, hypermarkets, supermarkets, or other distribution channels. Also, the switch from prescription to OTC drugs and increased government reforms and support in the form of investments in the pharmaceutical sector are contributing to the growth of the segment.
Geography
North America
Asia
Europe
Rest Of World (ROW)
33% of the market growth will come from North America during the forecast period. Factors such as the surge in the number of skin diseases, the rapid technological advances in the pharmaceutical sector, and the growth of the geriatric population are driving the growth of the regional market. Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our consumer healthcare market report covers the following areas:
We provide a detailed analysis of around 25 vendors operating in the consumer healthcare market, including some of the dominant vendors. Backed with competitive intelligence and benchmarking, our research report on the consumer healthcare market is designed to provide entry support, customer profile, and M&As as well as go-to-market strategy support.
North America, Asia, Europe, and Rest of World (ROW)
Performing market contribution
North America at 33%
Key consumer countries
US, Canada, UK, Germany, and China
Competitive landscape
Leading companies, competitive strategies, consumer engagement scope
Companies profiled
Abbott Laboratories, Amway Corp., BASF SE, Bayer AG, BioGaia AB, Boehringer Ingelheim International GmbH, Chr Hansen Holding AS, Danone SA, Eisai Co. Ltd., Genomma Lab Internacional SAB de CV, Glanbia Plc, GlaxoSmithKline Plc, Herbalife Nutrition Ltd., Himalaya Global Holdings Ltd., Johnson and Johnson, Kellogg Co., Koninklijke DSM NV, Merck KGaA, Nestle SA, NUTRITION ET SANTE, Pfizer Inc., Reckitt Benckiser Group PLC, and Sanofi
Market Dynamics
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period.
Customization purview
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
Table Of Contents:
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary ? Chart on Market Overview
Exhibit 02: Executive Summary ? Data Table on Market Overview
Exhibit 03: Executive Summary ? Chart on Global Market Characteristics
Exhibit 04: Executive Summary ? Chart on Market by Geography
Exhibit 05: Executive Summary ? Chart on Market Segmentation by Product
Exhibit 06: Executive Summary ? Chart on Incremental Growth
Exhibit 07: Executive Summary ? Data Table on Incremental Growth
Exhibit 08: Executive Summary ? Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers ? Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers ? Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants ? Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes ? Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry ? Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Product
5.1 Market segments
Exhibit 24: Chart on Product - Market share 2021-2026 (%)
Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
5.2 Comparison by Product
Exhibit 26: Chart on Comparison by Product
Exhibit 27: Data Table on Comparison by Product
5.3 OTC pharmaceuticals - Market size and forecast 2021-2026
Exhibit 28: Chart on OTC pharmaceuticals - Market size and forecast 2021-2026 ($ billion)
Exhibit 29: Data Table on OTC pharmaceuticals - Market size and forecast 2021-2026 ($ billion)
Exhibit 35: Data Table on Dietary supplements - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Product
Exhibit 36: Market opportunity by Product ($ billion)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 38: Chart on Market share by geography 2021-2026 (%)
Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ billion)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Asia - Market size and forecast 2021-2026
Exhibit 46: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibit 47: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibit 48: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.5 Europe - Market size and forecast 2021-2026
Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ billion)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ billion)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 China - Market size and forecast 2021-2026
Exhibit 62: Chart on China - Market size and forecast 2021-2026 ($ billion)
Exhibit 63: Data Table on China - Market size and forecast 2021-2026 ($ billion)
Exhibit 64: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on China - Year-over-year growth 2021-2026 (%)
7.9 UK - Market size and forecast 2021-2026
Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ billion)
Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.10 Germany - Market size and forecast 2021-2026
Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.11 Canada - Market size and forecast 2021-2026
Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ billion)
Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ billion)
Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity by geography
Exhibit 78: Market opportunity by geography ($ billion)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 79: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 81: Overview on factors of disruption
9.4 Industry risks
Exhibit 82: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 83: Vendors covered
10.2 Market positioning of vendors
Exhibit 84: Matrix on vendor position and classification
10.3 Abbott Laboratories
Exhibit 85: Abbott Laboratories - Overview
Exhibit 86: Abbott Laboratories - Business segments
Exhibit 87: Abbott Laboratories - Key news
Exhibit 88: Abbott Laboratories - Key offerings
Exhibit 89: Abbott Laboratories - Segment focus
10.4 Amway Corp.
Exhibit 90: Amway Corp. - Overview
Exhibit 91: Amway Corp. - Product / Service
Exhibit 92: Amway Corp. - Key news
Exhibit 93: Amway Corp. - Key offerings
10.5 BASF SE
Exhibit 94: BASF SE - Overview
Exhibit 95: BASF SE - Business segments
Exhibit 96: BASF SE - Key news
Exhibit 97: BASF SE - Key offerings
Exhibit 98: BASF SE - Segment focus
10.6 Bayer AG
Exhibit 99: Bayer AG - Overview
Exhibit 100: Bayer AG - Business segments
Exhibit 101: Bayer AG - Key offerings
Exhibit 102: Bayer AG - Segment focus
10.7 BioGaia AB
Exhibit 103: BioGaia AB - Overview
Exhibit 104: BioGaia AB - Product / Service
Exhibit 105: BioGaia AB - Key news
Exhibit 106: BioGaia AB - Key offerings
10.8 Boehringer Ingelheim International GmbH
Exhibit 107: Boehringer Ingelheim International GmbH - Overview
Exhibit 108: Boehringer Ingelheim International GmbH - Business segments
Exhibit 109: Boehringer Ingelheim International GmbH - Key news
Exhibit 110: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 111: Boehringer Ingelheim International GmbH - Segment focus
10.9 GlaxoSmithKline Plc
Exhibit 112: GlaxoSmithKline Plc - Overview
Exhibit 113: GlaxoSmithKline Plc - Business segments
Exhibit 114: GlaxoSmithKline Plc - Key news
Exhibit 115: GlaxoSmithKline Plc - Key offerings
Exhibit 116: GlaxoSmithKline Plc - Segment focus
10.10 Johnson and Johnson
Exhibit 117: Johnson and Johnson - Overview
Exhibit 118: Johnson and Johnson - Business segments
Exhibit 119: Johnson and Johnson - Key news
Exhibit 120: Johnson and Johnson - Key offerings
Exhibit 121: Johnson and Johnson - Segment focus
10.11 Pfizer Inc.
Exhibit 122: Pfizer Inc. - Overview
Exhibit 123: Pfizer Inc. - Product / Service
Exhibit 124: Pfizer Inc. - Key news
Exhibit 125: Pfizer Inc. - Key offerings
10.12 Sanofi
Exhibit 126: Sanofi - Overview
Exhibit 127: Sanofi - Business segments
Exhibit 128: Sanofi - Key news
Exhibit 129: Sanofi - Key offerings
Exhibit 130: Sanofi - Segment focus
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 131: Inclusions checklist
Exhibit 132: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 133: Currency conversion rates for US$
11.4 Research methodology
Exhibit 134: Research methodology
Exhibit 135: Validation techniques employed for market sizing
Exhibit 136: Information sources
11.5 List of abbreviations
Exhibit 137: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...
Banco Latinoamericano de Comercio Exterior, S.A. , a Panama-based multinational bank originally established by the central banks of 23 Latin-American and Caribbean countries to promote foreign trade and economic integration in the Region, announced...